Arnold KS, Balestra ME, Krauss RM, Curtiss LK, Young SG, Innerarity TL (1994) Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects. J. Lipid Res. 35:1469–1476.
Askanas V, Mirabella M, Engel WK, Alvarez RB, Weisgraber KH (1994) Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases. Lancet 343:364–365.
Brooks AR, Nagy BP, Taylor S, Simonet WS, Taylor JM, Levy-Wilson B (1994) Sequences containing the second-intron enhancer are essential for transcription of the human apolipoprotein B gene in the livers of transgenic mice. Mol. Cell. Biol. 14:2243–2256.
Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, Coughlin SR (1994) Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. USA 91:2752–2756.
Cudney B, Patel S, Weisgraber K, Newhouse Y, McPherson A (1994) Screening and optimization strategies for macromolecular crystal growth. Acta Crystallogr. D 50:414–423.
de Silva HV, Lauer SJ, Wang J, Simonet WS, Weisgraber KH, Mahley RW, Taylor JM (1994) Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J. Biol. Chem. 269:2324–2335.
de Silva HV, Más-Oliva J, Taylor JM, Mahley RW (1994) Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. J. Lipid Res. 35:1297–1310.
Dong J-F, Li CQ, López JA (1994) Tyrosine sulfation of the GP Ib-IX complex: Identification of sulfated residues and effect on ligand binding. Biochemistry 33:13946–13953.
Dong L-M, Wilson C, Wardell MR, Simmons T, Mahley RW, Weisgraber KH, Agard DA (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269:22358–22365.
Fan J, Wang J, Bensadoun A, Lauer SJ, Dang Q, Mahley RW, Taylor JM (1994) Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA 91:8724–8728.
Fazio S, Horie Y, Simonet WS, Weisgraber KH, Taylor JM, Rall SC Jr (1994) Altered lipoprotein metabolism in transgenic mice expressing low levels of a human receptor-binding-defective apolipoprotein E variant. J. Lipid Res. 35:408–416.
Fazio S, Marotti KR, Lee Y-L, Castle CK, Melchior GW, Rall SC Jr (1994) Co-expression of cholesteryl ester transfer protein and defective apolipoprotein E in transgenic mice alters plasma cholesterol distribution. Implications for the pathogenesis of type III hyperlipoproteinemia. J. Biol. Chem. 269:32368–32372.
Fazio S, Sanan DA, Lee Y-L, Ji Z-S, Mahley RW, Rall SC Jr (1994) Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142). Arterioscler. Thromb. 14:1873–1879.
Gabel B, Yao Z, McLeod RS, Young SG, Koschinsky ML (1994) Carboxyl-terminal truncation of apolipoproteinB-100 inhibits lipoprotein(a) particle formation. FEBS Lett. 350:77–81.
Han S-H, Einstein G, Weisgraber KH, Strittmatter WJ, Saunders AM, Pericak-Vance M, Roses AD, Schmechel DE (1994) Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53:535–544.
Huang DY, Goedert M, Jakes R, Weisgraber KH, Garner CC, Saunders AM, Pericak-Vance MA, Schmechel DE, Roses AD, Strittmatter WJ (1994) Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: Implications for Alzheimer’s disease. Neurosci. Lett. 182:55–58.
Ji Z-S, Fazio S, Lee Y-L, Mahley RW (1994) Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269:2764–2772.
Ji Z-S, Fazio S, Mahley RW (1994) Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J. Biol. Chem. 269:13421–13428.
Ji Z-S, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RW (1994) Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J. Biol. Chem. 269:13429–13436.
Ji Z-S, Mahley RW (1994) Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor–related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler. Thromb. 14:2025–2032.
López JA (1994) The platelet glycoprotein Ib–IX complex. Blood Coagul. Fibrinolysis 5:97–119.
López JA, Weisman S, Sanan DA, Sih T, Chambers M, Li CQ (1994) Glycoprotein (GP) Ibb is the critical subunit linking GP Iba and GP IX in the GP Ib-IX complex. Analysis of partial complexes. J. Biol. Chem. 269:23716–23721.
López JA, Weisman S, Sih T, Li CQ, Sanan DA (1994) Association of GP Ib with actin-binding protein does not require GP IX. Blood Coagul. Fibrinolysis 5:479–485.
Lüttmann S, von Eckardstein A, Wei W, Funke H, Kshler E, Mahley RW, Assmann G (1994) Electrophoretic screening for genetic variation in apolipoprotein C-III: Identification of a novel apoC-III variant, apoC-III(Asp45→Asn), in a Turkish patient. J. Lipid Res. 35:1431–1440.
Mahley RW, Bersot TP (1994) Lipid abnormalities: Mechanisms, clinical classifications, and management. In: Cardiology (Parmley WW, Chatterjee K, eds) JB Lippincott, Philadelphia, pp 1–20.
Mahley RW, Ji Z-S, Brecht WJ, Miranda RD, He D (1994) Role of heparan sulfate proteoglycans and the LDL receptor–related protein in remnant lipoprotein metabolism. Ann. N.Y. Acad. Sci. 737:39–52.
Mas-Oliva J, Arnold KS, Wagner WD, Phillips DR, Pitas RE, Innerarity TL (1994) Isolation and characterization of a platelet-derived macrophage-binding proteoglycan. J. Biol. Chem. 269:10177–10183.
McCormick SPA, Linton MF, Hobbs HH, Taylor S, Curtiss LK, Young SG (1994) Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein(a). J. Biol. Chem. 269:24284–24289.
McCormick SPA, Linton MF, Young SG (1994) Expression of P1 DNA in mammalian cells and transgenic mice. Genet. Anal. Tech. Appl. 11:158–164.
Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850–852.
Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, Strittmatter WJ (1994) Apolipoprotein E associates with b amyloid peptide of Alzheimer’s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J. Clin. Invest. 94:860–869.
Schwarzman AL, Gregori L, Vitek MP, Lyubski S, Strittmatter WJ, Enghilde JJ, Bhasin R, Silverman J, Weisgraber KH, Coyle PK, Zagorski MG, Talafous J, Eisenberg M, Saunders AM, Roses AD, Goldgaber D (1994) Transthyretin sequesters amyloid b protein and prevents amyloid formation. Proc. Natl. Acad. Sci. USA 91:8368–8372.
Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong L-M, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 91:11183–11186.
Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong L-M, Jakes R, Alberts MJ, Gilbert JR, Han S-H, Hulette C, Einstein G, Schmechel DE, Pericak-Vance MA, Roses AD (1994) Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125:163–171.
Swaney JB, Weisgraber KH (1994) Effect of apolipoprotein C-I peptides on the apolipoprotein E content and receptor-binding properties of beta-migrating very low density lipoproteins. J. Lipid Res. 35:134–142.
Weisgraber KH (1994) Apolipoprotein E: Structure–function relationships. Adv. Protein Chem. 45:249–302.
Weisgraber KH, Newhouse YM, McPherson A (1994) Crystallization and preliminary X-ray analysis of human plasma apolipoprotein C-I. J. Mol. Biol. 236:382–384.
Weisgraber KH, Pitas RE, Mahley RW (1994) Lipoproteins, neurobiology, and Alzheimer’s disease: Structure and function of apolipoprotein E. Curr. Opin. Struct. Biol. 4:507–515.
Weisgraber KH, Roses AD, Strittmatter WJ (1994) The role of apolipoprotein E in the nervous system. Curr. Opin. Lipidol. 5:110–116.
Wilson C, Mau T, Weisgraber KH, Wardell MR, Mahley RW, Agard DA (1994) Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein. Structure 2:713–718.
Yamanaka S, Poksay KS, Balestra ME, Zeng G-Q, Innerarity TL (1994) Cloning and mutagenesis of the rabbit apoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed. J. Biol. Chem. 269:21725–21734.
Young SG, Bihain B, Flynn LM, Sanan DA, Ayrault-Jarrier M, Jacotot B (1994) Asymptomatic homozygous hypobetalipoproteinemia associated with apolipoprotein B45.2. Hum. Mol. Genet. 3:741–744.
Young SG, Farese RV Jr, Pierotti VR, Taylor S, Grass DS, Linton MF (1994) Transgenic mice expressing human apoB100 and apoB48. Curr. Opin. Lipidol. 5:94–101.
Young SG, Koduri RK, Austin RK, Bonnet DJ, Smith RS, Curtiss LK (1994) Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47. J. Lipid Res. 35:399–407.
Young SG, Parthasarathy S (1994) Why are low-density lipoproteins atherogenic? West. J. Med. 160:153–164.
Zysow BR, Pullinger CR, Hennessy LK, Farese RV Jr, Ghassemzadeh M, Kane JP (1994) The apolipoprotein C-II variant apoC-IILys19→Thr is not associated with dyslipidemia in an affected kindred. Clin. Genet. 45:292–297.
TOP
